Traxi Panniculus Retractor for Cesarean Delivery
NCT: NCT03651076 · TERMINATED
NCT IDNCT03651076
StatusTERMINATED
Start Date2018-10-02
Completion2025-02-01
SponsorBeth Israel Deaconess Medical Center (OTHER)
First posted
Last updated
Brief Summary
This prospective, open-label, randomized-controlled trial is designed to evaluate the use of the Traxi panniculus retractor-- a commercially available Class I FDA-exempt device will improve surgical outcomes, cardiopulmonary function, and provider/patient satisfaction in morbidly obese women undergoing cesarean delivery.
Frequently Asked Questions
What is Traxi Panniculus Retractor for Cesarean Delivery?
Traxi Panniculus Retractor for Cesarean Delivery is a clinical trial registered under NCT03651076. Current status: TERMINATED.
What is the status of NCT03651076?
The current status of NCT03651076 (Traxi Panniculus Retractor for Cesarean Delivery) is: TERMINATED.
When did Traxi Panniculus Retractor for Cesarean Delivery start?
Traxi Panniculus Retractor for Cesarean Delivery started on 2018-10-02.
Official Source
View on ClinicalTrials.gov →Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.